- Home
- Publications
- Publication Search
- Publication Details
Title
Irinotecan pharmacogenomics
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 11, Issue 7, Pages 1003-1010
Publisher
Future Medicine Ltd
Online
2010-07-06
DOI
10.2217/pgs.10.95
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells
- (2010) Anne-Sophie Belanger et al. BMC MOLECULAR BIOLOGY
- Individualizing Dosing of Irinotecan
- (2010) M. J. Ratain et al. CLINICAL CANCER RESEARCH
- A CYP3A4 Phenotype-Based Dosing Algorithm for Individualized Treatment of Irinotecan
- (2010) J. M. van der Bol et al. CLINICAL CANCER RESEARCH
- Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
- (2010) Caroline Raynal et al. Molecular Cancer
- Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer
- (2009) Heather Taffet Gold et al. CANCER
- Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients
- (2009) Kimie Sai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on theUGT1A1*28polymorphism
- (2009) Shoichi Hazama et al. CANCER SCIENCE
- UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
- (2009) Masahide Onoue et al. International Journal of Clinical Oncology
- The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens
- (2009) Mehmet Artac et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- UGT1A and Irinotecan Toxicity: Keeping It in the Family
- (2009) Janelle M. Hoskins et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial
- (2009) Michael S. Braun et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Role of the UGT1A1, UGT1A7, and UGT1A9 Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan
- (2009) Erika Cecchin et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics
- (2009) Federico Innocenti et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124
- (2009) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer
- (2009) Giuseppe Toffoli et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers
- (2009) Masashi Takano et al. ONCOLOGY
- Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan
- (2009) Janelle M Hoskins et al. PHARMACOGENOMICS
- UGT1A1 gene polymorphism: Impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer
- (2009) Christoph Schulz et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Association of ATP-Binding Cassette, Sub-family C, Number 2 (ABCC2) Genotype with Pharmacokinetics of Irinotecan in Japanese Patients with Metastatic Colorectal Cancer Treated with Irinotecan Plus Infusional 5-Fluorouracil/Leucovorin (FOLFIRI)
- (2008) Ken-ichi Fujita et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma
- (2008) Hiroki Yano et al. CANCER SCIENCE
- Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes
- (2008) J. M. Hoskins et al. CLINICAL CANCER RESEARCH
- Close Association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 Haplotype and Its Apparent Influence on 7-Ethyl-10-hydroxycamptothecin (SN-38) Glucuronidation in Japanese
- (2008) Y. Saito et al. DRUG METABOLISM AND DISPOSITION
- Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer
- (2008) Ji-Youn Han et al. LUNG CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation